Evidence map›Paper›PMID 21743471›Full record

ArticleNature neuroscience2011

Neurod6 expression defines new retinal amacrine cell subtypes and regulates their fate.

Jeremy N Kay, P Emanuela Voinescu, Monica W Chu, Joshua R Sanes

Open access · greenAbstract read
In one paragraph

Article in Nature neuroscience, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 1 synthesis or guideline pooled it, 121 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Role of PKN1 in Retinal Cell Type Formation.International journal of molecular sciences · 2024
    Article
  9. Article
  10. The Journal of neuroscience : the official journal of the Society for Neuroscience · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Identification of TPBG-Expressing Amacrine Cells in DAT-tdTomato Mouse.Investigative ophthalmology & visual science · 2022
    Article
  15. The meLife · 2022
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Simultaneous deletion ofDevelopment (Cambridge, England) · 2020
    Article

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jeremy N KayCenter for Brain Science, Harvard University, Cambridge, Massachusetts, USA.
P Emanuela Voinescu
Monica W Chu
Joshua R Sanes
Harvard University · US

Funding

Synaptic Choices in the Retinotectal SystemR01NS029169 · NINDS · WASHINGTON UNIVERSITY · PI SANES, JOSHUA R · 1991 to 2012
$6.0M
Howard Hughes Medical Institute 43667NINDS NIH HHS R01 NS029169
6 · The paper itself

Abstract

Most regions of the CNS contain many subtypes of inhibitory interneurons with specialized roles in circuit function. In the mammalian retina, the ∼30 subtypes of inhibitory interneurons called amacrine cells (ACs) are generally divided into two groups: wide/medium-field GABAergic ACs and narrow-field glycinergic ACs, which mediate lateral and vertical interactions, respectively, within the inner plexiform layer. We used expression profiling and mouse transgenic lines to identify and characterize two closely related narrow-field AC subtypes. Both arise postnatally and one is neither glycinergic nor GABAergic (nGnG). Two transcription factors selectively expressed by these subtypes, Neurod6 and special AT-rich-sequence-binding protein 2 (Satb2), regulate a postmitotic cell fate choice between these subtypes. Satb2 induces Neurod6, which persists in nGnG ACs and promotes their fate but is downregulated in the related glycinergic AC subtype. Our results support the view that cell fate decisions made in progenitors and their progeny act together to diversify ACs.

Indexed as

Amacrine CellsAnimalsAnimals, NewbornBasic Helix-Loop-Helix ProteinsBromodeoxyuridineElectroporationEmbryo, Mammaliangamma-Aminobutyric AcidGene Expression Regulation, DevelopmentalGlutamate DecarboxylaseGlycineGlycine Plasma Membrane Transport ProteinsIn Vitro TechniquesLuminescent ProteinsMacacaMatrix Attachment Region Binding ProteinsBasic Helix-Loop-Helix ProteinsBromodeoxyuridineEbf2 protein, mousegamma-Aminobutyric AcidGlutamate Decarboxylaseglutamate decarboxylase 1glutamate decarboxylase 2GlycineGlycine Plasma Membrane Transport ProteinsLuminescent ProteinsMatrix Attachment Region Binding ProteinsNerve Tissue ProteinsNeurod6 protein, mouseSATB2 protein, mouseShiga Toxin 1Slc6a9 protein, mouseTranscription Factors

Identifiers

PMID21743471
PMCPMC3144989
OpenAlexW2093347794

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.